Financial statements IFRS 203 Performance review Aviva plc Notes to the consolidated financial statements continued Annual Report and Accounts 2010 Corporate responsibility Governance Shareholder information Financial statements IFRS Financial statements MCEV Other information 6 Details of expenses This note gives further detail on the items appearing in the second section of the consolidated income statement.
2010 2009 m m Claims and benefits paid Claims and benefits paid to policyholders on long-term business Insurance contracts 17,761 16,973 Participating investment contracts 5,338 4,264 Non-participating investment contracts 39 67 Claims and benefits paid to policyholders on general insurance and health business 7,194 7,444 30,332 28,748 Less: Claim recoveries from reinsurers Insurance contracts 1,030 1,083 Participating investment contracts 150 116 Claims and benefits paid, net of recoveries from reinsurers 29,152 27,549 Change in insurance liabilities Change in insurance liabilities 6,270 5,755 Change in reinsurance asset for insurance provisions 907 73 Change in insurance liabilities, net of reinsurance 7,177 5,682 Change in investment contract provisions Investment income allocated to investment contracts 3,907 5,136 Other changes in provisions Participating investment contracts note 40 4,825 5,764 Non-participating investment contracts 2 5,425 Change in reinsurance asset for investment contract provisions 7 5,710 Change in investment contract provisions 8,741 11,185 Change in unallocated divisible surplus note 44 329 1,547 Fee and commission expense Acquisition costs Commission expenses for insurance and participating investment contracts 3,010 2,953 Change in deferred acquisition costs for insurance and participating investment contracts 573 536 Deferrable costs for non-participating investment contracts 141 112 Other acquisition costs 1,276 1,137 Change in deferred acquisition costs for non-participating investment contracts 29 31 Investment income attributable to unitholders 1,586 331 Reinsurance commissions and other fee and commission expense 456 430 5,867 4,396 Other expenses Other operating expenses Staff costs note 10 1,677 1,845 Central costs and sharesave schemes 144 108 Depreciation note 20 77 115 Impairment losses on property and equipment note 20 3 2 Impairment of goodwill on subsidiaries and other amounts expensed note 16a 3 30 Amortisation of acquired value of in-force business on insurance contracts note 17 174 249 Amortisation of intangible assets note 17 197 142 Impairment of acquired value of in-force business note 17 13 Impairment of intangible assets note 17 21 12 Integration and restructuring costs see below 243 286 Exceptional items see below 220 776 Other expenses 1,102 1,113 3,421 4,691 Impairments Net impairment on loans 22 53 Net impairment on financial investments 179 538 Net impairment on receivables and other financial assets 1 2 Net impairment on non-financial assets 2 1 204 592 Other net foreign exchange gains losses 88 83 Finance costs note 7 1,422 1,519 Total expenses 55,567 57,244 Certain prior year disclosures in note 6 have been amended to conform to current year presentation 204 Aviva plc Notes to the consolidated financial statements continued Annual Report and Accounts 2010 6 Details of expenses continued Integration and restructuring costs Integration and restructuring costs were 243 million 2009: 286 million.
This includes expenditure relating to restructuring exercises across the group of 123 million, including UK restructuring costs of 53 million, 18 million in Delta Lloyd, 20 million in North America and 30 million in Aviva Investors.
Expenditure relating to the Quantum Leap project in Europe amounted to 40 million and costs associated with preparing the businesses for Solvency II implementation amounted to 59 million.
Costs incurred in 2009 mainly related to expenditure on cost saving programmes in the UK and Europe.
Exceptional items Exceptional items totalled 273 million net expense 2009: 45 million net income in the year.
For the year ended 31 December 2010, this comprised: 549 million recognised in Delta Lloyd which comprises of the cost of adopting new mortality tables of 483 million, German business closure, unit-linked insurance compensation scheme costs and compensation costs in defined contribution pension schemes of 66 million 286 million benefit from the closure of the final salary section of the UK staff pension scheme to future accruals.
10 million expense for the strengthening of reserves is in respect of several specific discontinued commercial liability risks written in Canada a significant number of years ago.
For the year ended 31 December 2009, this comprised: A net exceptional profit before tax of 207 million as a result of the reattribution of the inherited estate see note 45, of which 674 million was included in other expenses and 881 million credit was included in changes in unallocated divisible surplus: A 60 million expense for the strengthening of reserves in respect of several specific discontinued commercial liability risks written in Canada a significant number of years ago, which was included in change in insurance liabilities: and A 102 million expense for the migration of all remaining local brands, except Delta Lloyd and RAC, to the single global Aviva brand, which was implemented over the two-year period 2008 to 2009.
This cost was included in other expenses.
The table below sets out the lines of the income statement in which the exceptional items have been included: 2010 2009 m m Change in unallocated divisible surplus note 44 881 Change in insurance liabilities, net of reinsurance note 39 493 60 Other expenses as in the table above 220 776 273 45
